— Know what they know.
Not Investment Advice

LXRX NASDAQ

Lexicon Pharmaceuticals, Inc.
1W: +1.1% 1M: -18.8% 3M: -21.6% YTD: +51.7% 1Y: +59.6% 3Y: +5.2% 5Y: -46.8%
$1.82
+0.00 (+0.00%)
 
Weekly Expected Move ±8.3%
$2 $2 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $808.4M mcap · 214M float · 1.51% daily turnover · Short 47% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
42.1 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -99.7%  ·  5Y Avg: 204.5%
Cost Advantage
43
Intangibles
51
Switching Cost
23
Network Effect
78
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. LXRX shows a Weak competitive edge (42.1/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. Negative ROIC of -99.7% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$6
Avg Target
$6
High
Based on 1 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 5Hold: 7Sell: 2Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$6.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-03-12 H.C. Wainwright Joseph Pantginis Initiated $6 — +252.5% $1.70
2024-10-18 Leerink Partners Roanna Ruiz Initiated $6 — +198.5% $2.01

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
Oct 02, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. LXRX receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-08-07 C- D+
2026-05-11 D+ C-
2026-04-01 C- D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 23 Grade D
Profitability
20
Balance Sheet
55
Earnings Quality
63
Growth
48
Value
33
Momentum
50
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. LXRX scores highest in Earnings Quality (63/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-2.79
Distress Zone
Piotroski F-Score
3/9
✗ ✗ ✓ ✗ ✓ ✓ ✗ ✗ ✗
Beneish M-Score
17.53
Possible Manipulator
Ohlson O-Score
-5.78
Bankruptcy prob: 0.3%
Low Risk
Credit Rating
B+
Score: 31.5/100
Trend: Stable
Earnings Quality
—
OCF/NI: 1.30x
Accruals: 7.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. LXRX scores -2.79, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. LXRX scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. LXRX's score of 17.53 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. LXRX's implied 0.3% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. LXRX receives an estimated rating of B+ (score: 31.5/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-12.10x
PEG
0.10x
P/S
19.49x
P/B
4.56x
P/FCF
-13.18x
P/OCF
—
EV/EBITDA
-17.59x
EV/Revenue
22.16x
EV/EBIT
-17.43x
EV/FCF
-11.53x
Earnings Yield
-5.82%
FCF Yield
-7.59%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. LXRX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.159
EBT / EBIT
×
EBIT Margin
-1.272
EBIT / Rev
×
Asset Turnover
0.174
Rev / Assets
×
Equity Multiplier
1.565
Assets / Equity
=
ROE
-40.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. LXRX's ROE of -40.2% is driven by Asset Turnover (0.174), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$1.82
Median 1Y
$0.83
5th Pctile
$0.14
95th Pctile
$4.87
Ann. Volatility
110.5%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Michael S. Exton,
Ph.D. Chief Executive Officer and Director
$650,576 $1,049,304 $3,553,953

CEO Pay Ratio

8:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $3,553,953
Avg Employee Cost (SGA/emp): $460,728
Employees: 81

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
81
-21.4% YoY
Revenue / Employee
$614,852
Rev: $49,803,000
Profit / Employee
$-621,494
NI: $-50,341,000
SGA / Employee
$460,728
Avg labor cost proxy
R&D / Employee
$754,580
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -60.3% -65.0% -73.6% -93.0% -69.2% -88.4% -1.2% -1.0% -1.1% -1.7% -1.0% -94.8% -1.4% -1.7% -86.1% -65.3% -45.9% -39.7% -16.0% -40.2% -40.21%
ROA -38.5% -51.5% -54.8% -68.2% -53.3% -61.6% -73.9% -60.9% -67.4% -83.6% -66.8% -58.6% -72.4% -75.9% -49.6% -40.3% -26.0% -20.8% -9.2% -25.7% -25.70%
ROIC -1.8% -2.4% -2.2% -2.2% -2.0% -2.3% -2.3% -2.9% -4.5% -4.7% -3.7% -4.4% -7.8% -9.5% -4.7% -2.0% -84.7% -52.5% -21.3% -99.7% -99.68%
ROCE -50.0% -75.9% -76.4% -1.0% -54.9% -57.9% -74.4% -43.0% -61.0% -83.4% -45.6% -54.3% -70.6% -69.7% -83.1% -51.7% -26.6% -25.6% -7.0% -22.4% -22.41%
Gross Margin 1.0% -1177.4% -1.9% 1.0% 1.0% -2.7% 1.0% 97.5% 95.7% -20.1% 84.5% 89.9% 95.9% 2.3% 97.6% 99.3% 99.9% 94.2% 99.5% 94.4% 94.36%
Operating Margin -998.3% -1809.3% -631.9% -685.9% -592.2% -1081.4% -1297.6% -139.6% -306.4% -66.6% -40.1% -33.6% -36.4% -1.2% -20.3% 12.9% -85.9% -2.7% -4.7% -38.4% -38.35%
Net Margin -1005.3% -1829.4% -634.5% -702.5% -599.7% -1089.1% -1330.6% -141.7% -311.9% -70.9% -42.8% -32.4% -37.0% -1.3% -20.0% 11.3% -90.0% -2.8% -4.9% -45.9% -45.92%
EBITDA Margin -993.5% -1801.3% -628.6% -679.3% -574.7% -1046.0% -1250.0% -135.0% -286.9% -64.3% -39.3% -31.0% -34.4% -76.5% -18.5% 19.9% -73.8% -2.4% 3.1% -42.0% -42.00%
FCF Margin -206.4% -296.1% -281.0% -808.6% -721.7% -648.8% -782.1% -275.4% -253.5% -134.7% -80.3% -53.9% -39.9% -5.8% -5.4% -1.8% -1.0% -1.4% -55.7% -1.9% -1.92%
OCF Margin -203.8% -292.0% -276.9% -805.7% -720.9% -639.2% -770.2% -271.4% -250.3% -134.4% -80.2% -53.8% -39.7% -5.8% -5.4% -1.7% -1.0% -1.4% -55.7% -1.9% -1.92%
ROE 3Y Avg snapshot only -70.81%
ROE 5Y Avg snapshot only -83.85%
ROA 3Y Avg snapshot only -44.01%
ROIC Economic snapshot only -18.48%
Cash ROA snapshot only -31.88%
Cash ROIC snapshot only -1.85%
CROIC snapshot only -1.85%
NOPAT Margin snapshot only -1.04%
Pretax Margin snapshot only -1.47%
R&D / Revenue snapshot only 1.45%
SGA / Revenue snapshot only 85.23%
SBC / Revenue snapshot only 29.73%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -10.37 -6.68 -3.45 -2.87 -4.32 -3.54 -4.16 -3.59 -1.69 -2.12 -3.04 -2.58 -2.62 -1.33 -0.94 -2.85 -7.15 -8.30 -23.93 -17.19 -12.101
P/S Ratio 1452.16 1968.64 1012.09 2553.08 3358.16 2593.29 3645.27 1149.39 502.77 310.98 254.84 143.42 108.54 8.59 5.35 5.88 6.92 8.39 8.97 25.33 19.495
P/B Ratio 5.13 5.16 3.36 3.93 2.91 3.08 5.22 2.52 1.91 4.02 2.04 2.18 3.18 1.83 1.36 2.66 4.08 3.89 3.08 6.02 4.564
P/FCF -7.04 -6.65 -3.60 -3.16 -4.65 -4.00 -4.66 -4.17 -1.98 -2.31 -3.17 -2.66 -2.72 -1.48 -0.99 -3.35 -6.76 -6.16 -16.09 -13.18 -13.176
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -8.84 -5.79 -2.81 -2.54 -3.32 -2.81 -3.88 -2.55 -1.04 -1.89 -1.90 -1.70 -2.04 -0.78 -0.48 -2.67 -8.96 -9.28 -29.32 -17.59 -17.589
EV/Revenue 1231.22 1685.20 814.08 2217.80 2513.56 1995.71 3245.69 778.82 291.04 257.90 146.94 87.32 78.48 4.42 2.36 4.48 6.11 7.71 7.34 22.16 22.162
EV/EBIT -8.62 -5.77 -2.80 -2.53 -3.30 -2.80 -3.86 -2.54 -1.04 -1.88 -1.89 -1.69 -2.04 -0.78 -0.47 -2.66 -8.84 -9.14 -28.42 -17.43 -17.428
EV/FCF -5.97 -5.69 -2.90 -2.74 -3.48 -3.08 -4.15 -2.83 -1.15 -1.91 -1.83 -1.62 -1.97 -0.76 -0.44 -2.55 -5.96 -5.66 -13.18 -11.53 -11.529
Earnings Yield -9.6% -15.0% -29.0% -34.8% -23.1% -28.3% -24.0% -27.9% -59.1% -47.3% -32.9% -38.7% -38.1% -75.1% -1.1% -35.1% -14.0% -12.0% -4.2% -5.8% -5.82%
FCF Yield -14.2% -15.0% -27.8% -31.7% -21.5% -25.0% -21.5% -24.0% -50.4% -43.3% -31.5% -37.6% -36.7% -67.4% -1.0% -29.9% -14.8% -16.2% -6.2% -7.6% -7.59%
PEG Ratio snapshot only 0.095
Price/Tangible Book snapshot only 8.081
EV/Gross Profit snapshot only 22.419
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 3.62 4.02 4.68 3.85 7.54 6.08 5.38 10.10 6.92 5.60 15.58 11.51 7.45 5.44 2.22 4.16 5.64 4.88 18.79 13.37 13.367
Quick Ratio 3.62 4.02 4.68 3.85 7.54 6.08 5.38 10.09 6.91 5.58 15.56 11.49 7.43 5.44 2.22 4.16 5.63 4.87 18.77 13.29 13.286
Debt/Equity 0.10 0.02 0.28 0.36 0.21 0.47 0.63 0.57 0.76 1.14 0.37 0.44 0.57 0.74 0.83 0.44 0.48 0.58 0.28 0.34 0.340
Net Debt/Equity -0.78 -0.74 -0.66 -0.52 -0.73 -0.71 -0.57 -0.81 -0.81 -0.69 -0.86 -0.85 -0.88 -0.89 -0.76 -0.63 -0.48 -0.32 -0.56 -0.75 -0.753
Debt/Assets 0.08 0.02 0.19 0.23 0.16 0.28 0.34 0.33 0.38 0.46 0.25 0.28 0.32 0.36 0.34 0.25 0.28 0.34 0.21 0.24 0.237
Debt/EBITDA -0.21 -0.03 -0.29 -0.27 -0.32 -0.56 -0.53 -0.85 -0.71 -0.65 -0.59 -0.56 -0.50 -0.62 -0.66 -0.58 -1.20 -1.50 -3.31 -1.13 -1.135
Net Debt/EBITDA 1.59 0.97 0.68 0.38 1.12 0.84 0.48 1.21 0.76 0.39 1.39 1.09 0.78 0.74 0.60 0.84 1.20 0.82 6.48 2.51 2.513
Interest Coverage -101.88 -108.58 -120.28 -74.69 -48.23 -35.67 -23.58 -21.74 -16.97 -12.59 -11.06 -11.39 -11.75 -11.33 -12.46 -7.84 -4.81 -5.04 -2.22 -6.29 -6.289
Equity Multiplier 1.26 1.21 1.47 1.59 1.33 1.66 1.85 1.70 1.98 2.46 1.44 1.56 1.80 2.04 2.42 1.74 1.71 1.72 1.33 1.43 1.433
Cash Ratio snapshot only 12.961
Debt Service Coverage snapshot only -6.231
Cash to Debt snapshot only 3.215
FCF to Debt snapshot only -1.345
Defensive Interval snapshot only 734.8 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.02 0.12 0.09 0.20 0.27 0.21 0.25 0.17 0.174
Inventory Turnover — — — — — — — 1.29 0.70 77.94 58.45 40.11 31.37 86.09 73.29 69.70 65.95 2.22 2.71 0.70 0.698
Receivables Turnover 0.69 1.46 4.46 1.13 4.03 6.62 0.85 1.13 2.97 2.32 2.59 2.20 3.25 13.87 1.27 24.33 27.10 17.01 2.35 21.68 21.677
Payables Turnover 2.38 5.38 3.77 2.09 1.87 0.02 0.01 0.01 0.01 1.20 1.63 1.34 1.16 1.81 2.79 2.90 2.91 0.06 0.09 0.12 0.116
DSO 531 250 82 323 91 55 432 322 123 157 141 166 112 26 286 15 13 21 155 17 16.8 days
DIO 0 0 0 0 0 0 0 283 520 5 6 9 12 4 5 5 6 165 135 523 523.0 days
DPO 154 68 97 175 195 16827 34785 29345 33195 305 223 273 314 202 131 126 125 5746 3866 3160 3160.0 days
Cash Conversion Cycle 378 183 -15 148 -105 -16772 -34353 -28740 -32553 -143 -76 -98 -190 -172 161 -106 -106 -5560 -3576 -2620 -2620.2 days
Fixed Asset Turnover snapshot only 4.838
Operating Cycle snapshot only 539.8 days
Cash Velocity snapshot only 0.218
Capital Intensity snapshot only 6.030
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -98.5% -98.8% -98.1% -98.5% -74.1% -53.4% -59.1% 2.7% 3.2% 7.7% 17.3% 7.9% 8.8% 24.8% 12.5% 15.0% 12.6% 60.2% 1.2% -29.0% -29.03%
Net Income 35.1% -49.8% -6.0% -3.5% -43.5% -16.2% -22.3% -35.0% -62.6% -73.7% -75.3% -54.6% -37.1% -13.1% 8.4% 40.3% 68.3% 74.9% 85.3% 49.3% 49.33%
EPS 47.7% -23.1% -5.7% -3.5% -19.6% 8.4% 3.5% 1.3% -16.1% -33.9% -35.1% -1.9% 7.1% 23.3% 37.9% 49.0% 68.5% 75.0% 86.7% 57.9% 57.91%
FCF 25.1% 38.3% 40.8% 28.2% 9.5% -2.2% -13.9% -27.5% -49.2% -80.1% -88.4% -74.6% -54.8% -10.7% 9.3% 47.7% 65.2% 62.3% 77.0% 22.4% 22.36%
EBITDA 17.1% -1.1% -43.1% -3.2% -40.8% -13.8% -18.2% -30.9% -56.9% -66.5% -69.6% -50.3% -35.2% -7.0% 13.5% 47.7% 75.9% 76.5% 88.7% 46.7% 46.67%
Op. Income 20.9% -82.2% -13.5% -3.4% -38.4% -15.7% -21.1% -34.6% -62.1% -70.5% -71.3% -53.0% -35.9% -14.8% 4.6% 39.9% 68.3% 75.2% 86.3% 54.0% 53.96%
OCF Growth snapshot only 21.76%
Asset Growth snapshot only 10.85%
Equity Growth snapshot only 34.83%
Debt Growth snapshot only 3.97%
Shares Change snapshot only 20.38%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y -81.7% -83.2% -81.3% -86.3% -92.8% -92.4% -92.7% -89.2% -74.6% -63.1% -47.6% -19.9% 1.2% 3.7% 3.7% 7.1% 7.3% 6.1% 7.2% 3.7% 3.67%
Revenue 5Y -69.7% -67.6% -67.8% -73.4% -72.6% -72.6% -73.5% -66.7% -63.2% -54.7% -45.2% -38.9% -56.4% -37.4% -37.3% -28.8% 16.9% 15.7% 34.2% 42.4% 42.35%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — -95.8% -90.2% -76.0% — — — — — — — — — 13.4% 4.2% 4.17%
Gross Profit 5Y — — — — — — -81.1% -68.5% -64.8% — — — — -56.9% -56.4% -36.7% 8.4% 18.5% 1.3% — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y -17.8% -21.6% -19.2% -21.6% -24.5% -22.5% -24.0% -0.6% 15.6% 4.0% 29.2% 29.6% 23.1% 29.7% 29.8% 26.2% 2.4% -1.6% 18.2% -7.6% -7.58%
Assets 5Y -19.7% -22.0% -19.2% -20.9% -10.3% -14.9% -15.9% -1.0% -2.3% -4.2% 10.0% 9.9% -6.3% -6.5% -4.3% -6.9% 2.9% -1.9% 6.8% 7.8% 7.81%
Equity 3Y — — — — -4.4% 0.0% 17.1% — 16.8% -15.9% 23.7% 20.5% 9.3% 8.7% 9.9% 22.3% -5.9% -2.8% 32.1% -2.2% -2.16%
Book Value 3Y — — — — -16.5% -17.4% -3.2% — -8.6% -33.2% 3.4% -6.7% -19.2% -19.1% -18.2% -9.1% -26.2% -21.9% 2.9% -24.0% -24.05%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.22 0.04 0.04 0.03 0.20 0.23 0.25 0.25 0.86 0.84 0.81 0.71 0.65 0.59 0.59 0.51 0.09 0.24 0.45 0.50 0.498
Earnings Stability 0.01 0.15 0.25 0.31 0.00 0.00 0.00 0.00 0.16 0.26 0.40 0.46 0.73 0.85 0.91 0.73 0.09 0.10 0.09 0.18 0.181
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.000
Earn. Growth Consistency 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.20 0.83 0.94 0.91 0.50 0.50 0.50 0.50 0.50 0.85 0.95 0.97 0.84 0.50 0.50 0.50 0.80 0.803
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend -0.40 -1.14 -1.71 — 0.17 -0.30 -0.72 -0.16 -0.55 -1.08 0.44 0.19 -0.31 0.01 -0.48 -0.16 0.60 1.17 0.93 0.54 0.537
Gross Margin Trend -49.35 -132.03 -86.75 -150.63 -108.12 64.58 43.26 77.63 90.90 54.49 37.52 72.15 63.62 6.08 2.82 1.77 1.20 6.57 3.66 2.30 2.298
FCF Margin Trend -204.50 -293.30 -276.59 -800.06 -616.47 -497.72 -637.03 137.50 210.49 337.68 451.19 488.12 447.77 385.96 425.80 162.90 145.68 68.90 42.30 25.90 25.895
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.46 0.99 0.94 0.91 0.93 0.87 0.88 0.85 0.84 0.91 0.96 0.97 0.96 0.89 0.94 0.84 1.05 1.35 1.49 1.30 1.304
FCF/OCF 1.01 1.01 1.01 1.00 1.00 1.01 1.02 1.01 1.01 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 1.304
CapEx/Revenue 2.6% 4.1% 4.1% 2.9% 82.4% 9.5% 11.9% 4.0% 3.2% 39.0% 9.6% 9.1% 10.7% 3.3% 3.3% 1.3% 0.7% 0.0% 0.0% 0.0% 0.00%
CapEx/Depreciation snapshot only 0.000
Accruals Ratio 0.18 -0.00 -0.03 -0.06 -0.04 -0.08 -0.09 -0.09 -0.11 -0.07 -0.03 -0.02 -0.03 -0.08 -0.03 -0.06 0.01 0.07 0.04 0.08 0.078
Sloan Accruals snapshot only 0.299
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.4% 0.5% 0.3% 0.3% 0.2% 0.2% 0.2% 0.2% 0.3% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -14.8% -5.9% -6.2% -6.9% -22.3% -25.9% -20.3% -49.6% -51.7% -36.8% -23.6% -0.0% -0.0% -0.0% -0.1% -0.0% -0.0% -0.0% -15.5% -16.0% -15.97%
Total Shareholder Return -14.8% -5.9% -6.2% -6.9% -22.3% -25.9% -20.3% -49.6% -51.7% -36.8% -23.6% -0.0% -0.0% -0.0% -0.1% -0.0% -0.0% -0.0% -15.5% -16.0% -15.97%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 0.98 1.01 1.01 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.08 1.07 1.14 1.14 1.22 1.40 1.20 1.45 1.16 1.159
EBIT Margin -142.80 -292.21 -290.93 -876.43 -760.82 -713.41 -840.56 -306.30 -280.74 -136.91 -77.66 -51.56 -38.51 -5.68 -4.98 -1.69 -0.69 -0.84 -0.26 -1.27 -1.272
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.02 0.12 0.09 0.20 0.27 0.21 0.25 0.17 0.174
Equity Multiplier 1.57 1.26 1.34 1.36 1.30 1.44 1.65 1.67 1.65 2.02 1.54 1.62 1.88 2.21 1.74 1.62 1.76 1.91 1.74 1.56 1.565
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.46 $-0.59 $-0.61 $-0.65 $-0.55 $-0.54 $-0.58 $-0.64 $-0.64 $-0.72 $-0.79 $-0.65 $-0.60 $-0.55 $-0.49 $-0.33 $-0.19 $-0.14 $-0.07 $-0.14 $-0.14
Book Value/Share $0.94 $0.76 $0.62 $0.47 $0.82 $0.62 $0.47 $0.91 $0.57 $0.38 $1.18 $0.77 $0.49 $0.40 $0.34 $0.36 $0.33 $0.30 $0.51 $0.40 $0.40
Tangible Book/Share $0.63 $0.46 $0.32 $0.18 $0.57 $0.38 $0.23 $0.69 $0.39 $0.20 $1.00 $0.63 $0.37 $0.28 $0.22 $0.23 $0.21 $0.17 $0.40 $0.30 $0.30
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.01 $0.01 $0.01 $0.09 $0.09 $0.16 $0.20 $0.14 $0.17 $0.09 $0.09
FCF/Share $-0.68 $-0.59 $-0.58 $-0.59 $-0.52 $-0.48 $-0.52 $-0.55 $-0.55 $-0.66 $-0.76 $-0.63 $-0.58 $-0.50 $-0.47 $-0.28 $-0.20 $-0.19 $-0.10 $-0.18 $-0.18
OCF/Share $-0.67 $-0.58 $-0.57 $-0.59 $-0.52 $-0.47 $-0.51 $-0.54 $-0.54 $-0.66 $-0.76 $-0.63 $-0.57 $-0.49 $-0.46 $-0.28 $-0.20 $-0.19 $-0.10 $-0.18 $-0.18
Cash/Share $0.83 $0.58 $0.58 $0.41 $0.78 $0.73 $0.56 $1.25 $0.89 $0.69 $1.45 $1.00 $0.71 $0.66 $0.54 $0.38 $0.32 $0.26 $0.43 $0.44 $0.44
EBITDA/Share $-0.46 $-0.58 $-0.60 $-0.64 $-0.54 $-0.52 $-0.56 $-0.61 $-0.61 $-0.67 $-0.73 $-0.60 $-0.56 $-0.49 $-0.43 $-0.27 $-0.13 $-0.11 $-0.04 $-0.12 $-0.12
Debt/Share $0.10 $0.02 $0.17 $0.17 $0.18 $0.29 $0.29 $0.52 $0.43 $0.43 $0.43 $0.34 $0.28 $0.30 $0.28 $0.16 $0.16 $0.17 $0.14 $0.14 $0.14
Net Debt/Share $-0.73 $-0.57 $-0.41 $-0.24 $-0.60 $-0.44 $-0.27 $-0.74 $-0.46 $-0.26 $-1.02 $-0.66 $-0.43 $-0.36 $-0.26 $-0.23 $-0.16 $-0.09 $-0.28 $-0.30 $-0.30
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -2.793
Altman Z-Prime snapshot only -8.776
Piotroski F-Score 4 3 3 3 2 4 3 4 2 2 5 4 5 5 3 5 4 4 5 3 3
Beneish M-Score -29.10 -4.30 122.94 -26.33 -2.00 229.64 3.90 5.62 0.83 18.79 37.95 1.11 6.14 -425.80 22.23 11.59 3.69 -0.66 11.31 17.53 17.528
Ohlson O-Score snapshot only -5.778
ROIC (Greenblatt) snapshot only -27.69%
Net-Net WC snapshot only $0.28
EVA snapshot only $-47376770.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only B+
Credit Score 30.44 30.65 30.36 30.80 31.29 31.86 29.66 29.72 30.23 28.22 32.18 31.80 29.96 29.56 28.15 31.60 31.36 29.38 31.60 31.53 31.533
Credit Grade snapshot only 14
Credit Trend snapshot only -0.064
Implied Spread (bps) snapshot only 650.000
Industry Credit Rank snapshot only 23
Sector Credit Rank snapshot only 23

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms